top of page
바이오 디자이너스 최종.png

We will make
Your dreams come true!

BioDesigners is a company that grows together by discovering innovative bio and healthcare technologies.

COMMERCIALIZATION
PARTNERS

SERVICES
이뮤노 디자이너스 로고 원본.png

To develop a new immuno-related drug,

we co-founded IMMUNO DESIGNERS in December 2020 with Professor Bruce A. Beutler of the UT Southwestern Medical Center, a world-renowned scholar.

OUR TEAM

 

Lee, Dongho

-Professor, Hanyang University College of Medicine,

 Anesthesiology

-Yale University Medical School Hospital  visiting professor

-Vice President of GlaxoSmithKline Korea  Medical Director

-Vice President of Samyang Corporation Head of

 Pharmaceutical Business Division  Head of Research

 Center

-Professor of Anesthesia and Pain Medicine, Department of Clinical Pharmacology, Ulsan University College of Medicine

-Director, Clinical Research Center, Asan Medical Center, 

 Seoul

-Vice President of korea national enterprise for clinical trials(KoNECT) / Clinical Trial Center selection and guide

-Ceo of Korean Drug Development Fund(KDDF)

-Korea Pharmaceutical and Biotechnology Association AI

 Director of New Drug Development Support Center

 

Kim, Myung Hwa

- Master of Pharmacy and Doctor of Chemistry,

  University of Mainz,Germany
- Senior Researcher at Chugai Pharma, Fuji Gotemba

  Research Labs., Japan
- General Manager at the Central Research Institute of

  Citree Co., Ltd

- Director of Division of New Drud Development, R&D

  Centerb of Jeil Pharmaceutical Co., Ltd. Korea
- Director at R&D Center, Arimed Therapeutics. Korea

- CSO/Project Evaluation & Management Team Leader

  of Korea Drug Development Fund (KDDF)

- CSO/President at The Curacle Co., Ltd, Korea

 

Oh, Sungsoo

 -Solidus Global Bioagrifood Fund (17 billion won)

  Representative fund manager (completed  liquidation, 

  IRR 17%)

 -IBKC-Solidus Future Creation Bio-Secondary Refund

  Fund

  (30 billion won) Representative fund manager

 -KB-Solidus Global Healthcare Fund (150 billion won)

  Representative fund manager

 -2014 Solidus Growth Ladder Startup Fund

  (20 billion won) Core operating area

 -Pan-Ministry of Health and Welfare Development   

  Project Team  Investment Review Board

 -Korea Biotechnology Association  Advisory  Committee

 -Samsung Seoul Hospital, etc.  Evaluation Committee

 -Ministry of Welfare, Ministry of Industry, Ministry of

  Science and Technology, etc.  Government bio

  advisory&Evaluator

MEDIA COVERAGE

ARTICLES
bottom of page